BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cryo-Cell International (CCEL) C'elle(SM) Featured on ABC Action News in Tampa Bay Advances in Menstrual Stem Cell Technology May End Stem Cell Controversy


7/20/2009 9:45:34 AM

Oldsmar, Fla., July 20 /PRNewswire-FirstCall/ --Women today have a number of options when it comes to protecting their future health and possibly that of their families. Banking stem cells found in menstrual blood is one way in which women are looking to safeguard against potential future illnesses, conditions or injuries. Menstrual blood has been shown to contain self-renewing stem cells that may be stored for potential treatments in the future. A Florida-based company, Cryo-Cell International, Inc. offers C'elle, a service that empowers women to collect and preserve stem cells harvested from their own menstrual blood. Featured in a recent healthcare segment on ABC Action News in Tampa Bay, the promise of C'elle technology offers insightful perspectives from a C'elle client and from a stem cell researcher who is exploring development of Cryo-Cell's proprietary cutting edge technology for a potential neurological application.

Menstrual stem cells (MenSCs) potentially offer compelling advantages over stem cells obtained from other sources because they can be easily obtained from women in a painless, non-invasive manner, and they are an exact match for the woman donor and therefore the patient's rejection of tissue may be avoided. Since menstrual stem cells are harvested from a source that would otherwise be regarded as biological waste, there are no ethical questions that are associated with embryonic stem cells.

"We are clearly excited as Cryo-Cell continues to build a significant pipeline of strong research partnerships that are independently funded and that may possibly lead to breakthrough therapies for future human clinical studies," said Mercedes A. Walton, Chairman and CEO of Cryo-Cell. "We are also pleased to empower women with the opportunity to harvest and cryopreserve their own stem cells today for possible utilization in the future."

About C'elle

The C'elle(SM) service was introduced in November 2007 as the first and only service that empowers women to collect and cryopreserve menstrual flow containing undifferentiated adult stem cells for future utilization by the donor or possibly their first-degree relatives in a manner similar to umbilical cord blood stem cells. For more information, visit http://www.Celle.com

Forward-Looking Statement

SOURCE Cryo-Cell International, Inc.

CONTACT: General Media Inquiries, Kristin O'Neill, +1-312-233-1295,
Kristin.Oneill@edelman.com; or Financial Media Inquiries, Dianne Will,
Investor Relations, Cryo-Cell International, Inc., +1-518-398-6222,
dwill@willstar.net

Web site: http://www.cryo-cell.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES